{"doi":"10.1517/13543784.11.5.675","title":"Enzyme replacement therapy for the mucopolysaccharide storage disorders","abstract":null,"journal":"Expert Opinion on Investigational Drugs","year":2002,"id":14185,"datarank":3.6836812604452596,"base_score":4.143134726391533,"endowment":4.143134726391533,"self_citation_contribution":0.62147020895873,"citation_network_contribution":3.0622110514865297,"self_endowment_contribution":0.62147020895873,"citer_contribution":3.0622110514865297,"corpus_percentile":null,"corpus_rank":null,"citation_count":62,"citer_count":59,"citers_with_citation_signal":51,"citers_with_endowment":51,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":113213,"name":"Emil Kakkis","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.143134726391533,"endowment":4.143134726391533,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"11996648","pmcid":null,"openalex_id":"https://openalex.org/W2028706623","authors":[],"funders":[],"total_grants":0,"fwci":3.035,"citation_percentile":0.91161229,"influential_citations":1,"citation_trend":[{"year":2012,"count":5},{"year":2014,"count":2},{"year":2015,"count":3},{"year":2017,"count":2},{"year":2019,"count":1},{"year":2020,"count":2},{"year":2021,"count":1},{"year":2023,"count":3},{"year":2026,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://www.tandfonline.com/doi/pdf/10.1517/13543784.11.5.675","host_type":"publisher"},{"url":"https://doi.org/10.1517/13543784.11.5.675","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/11996648","host_type":"repository"}],"fields_of_study":["Lysosomal Storage Disorders Research","Trypanosoma species research and implications","Glycogen Storage Diseases and Myoclonus","Chemistry","Medicine","Animals","Cats","Clinical Trials, Phase I as Topic","Clinical Trials, Phase II as Topic","Disease Models, Animal","Dogs","Humans","Iduronidase","Mucopolysaccharidoses","Recombinant Proteins","Treatment Outcome"],"mesh_terms":["Animals","Cats","Disease Models, Animal","Dogs","Humans","Iduronidase","Mucopolysaccharidoses","Recombinant Proteins","Treatment Outcome","Clinical Trials, Phase I as Topic","Clinical Trials, Phase II as Topic"],"keywords":["Enzyme replacement therapy","Mucopolysaccharidosis","Glycosaminoglycan","Mucopolysaccharidosis I","Lysosomal storage disorders","Lysosomal storage disease","Medicine","Substrate reduction therapy","Enzyme","Disease","Pathology","Biochemistry","Chemistry","Anatomy"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Industry, innovation and infrastructure"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T05:43:59.418479Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}